使用氧化还原活性铁络合物对动脉瘤炎症进行分子磁共振成像
在兔囊状动脉瘤模型中评估氧化激活探针Fe-PyC3A用于动脉瘤炎症MRI的可行性,结果显示Fe-PyC3A在动态或延迟采集模式下对炎症程度较高的动脉瘤产生更高的MRI信号增强,支持进一步评估其作为动脉瘤炎症无创标志物。
要点
- Fe-PyC3A在4周组动脉瘤增强比显著高于12周组(1.6±0.30 vs 1.2±0.03,P<0.05)。
- 12周组MSDE/TSE序列注射后20分钟Fe-PyC3A增强比显著高于钆布醇(1.25±0.06 vs 1.03±0.03,P<0.05)。
- Fe-PyC3A动态成像血池和肌肉信号增强轻微,而钆布醇血池和肌肉增强明显。
核心结论
- Fe-PyC3A在动态或延迟采集模式下对炎症程度更高的动脉瘤产生更高的MRI信号增强,初步实验支持进一步评估其作为动脉瘤炎症无创标志物。
研究设计与样本
- 研究论文,兔囊状动脉瘤模型,在诱导后4周(n=4)或12周(n=4)使用3T临床扫描仪成像,参考标准为髓过氧化物酶活性荧光检测和钙卫蛋白免疫组化。
关键影像表现/征象
- Fe-PyC3A动态成像血池或邻近肌肉内信号增强轻微,但产生短暂的动脉瘤增强比升高;钆布醇动态成像产生强烈的动脉瘤增强,但血池和肌肉也强烈增强,导致相对增强比变化较小。
诊断标准与关键数值
- 体外弛豫测量显示过氧化氢氧化Fe-PyC3A使3T下r1增加15倍;血浆中r1增加不超过10%;动脉瘤增强比计算为注射后动脉瘤与骨骼肌对比度比值除以注射前对比度比值。
临床应用与阅片要点
- Fe-PyC3A动态成像4周组动脉瘤增强比为1.6±0.30,12周组为1.2±0.03(P<0.05);12周组MSDE/TSE序列注射后20分钟Fe-PyC3A增强比为1.25±0.06,钆布醇为1.03±0.03(P<0.05);免疫组化显示4周组白细胞浸润为123±37 cells/mm²,12周组为18±7 cells/mm²(P<0.05)。
局限性
- 作者指出结果来自初步实验,支持进一步评估,但未报告其他具体局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Inflammation plays a key role in driving brain aneurysmal instability and rupture, but clinical tools to noninvasively differentiate between inflamed and stable aneurysms are lacking. We hypothesize that imaging oxidative changes in the aneurysmal microenvironment driven by myeloid inflammatory cells may represent a noninvasive biomarker to evaluate rupture risk. In this study, we performed initial evaluation of the oxidatively activated probe Fe-PyC3A as a tool for magnetic resonance imaging (MRI) of inflammation in a rabbit model of saccular aneurysm.
MATERIALS AND METHODS: The difference in longitudinal relaxivity ( r1 ) in reduced and oxidized states of Fe-PyC3A was measured in water and blood plasma phantoms at 3 T. A rabbit saccular aneurysm model was created by endovascular intervention/elastinolysis with subsequent decellularization in situ. Rabbits were imaged at 4 weeks (n = 4) or 12 weeks (n = 4) after aneurysmal induction, when luminal levels of inflammation reflected by the presence of myeloperoxidase positive cells are relatively high and low, respectively, using a 3 T clinical scanner. Both groups were imaged dynamically using a 2-dimensional T1-weighted fast field echo pulse MRI sequence before and up to 4 minutes postinjection of Fe-PyC3A. Dynamic imaging was then repeated after an injection of gadobutrol (0.1 mmol/kg) as negative control probe. Rabbits from the 12-week aneurysm group were also imaged before and 20 minutes and 3 hours after injection of Fe-PyC3A using an axial respiratory gated turbo-spin echo (TSE) pulse sequence with motion-sensitized driven equilibrium (MSDE) preparation. The MSDE/TSE imaging was repeated before, immediately after dynamic acquisition (20 minutes postinjection), and 3 hours after injection of gadobutrol. Aneurysmal enhancement ratios (ERs) were calculated by dividing the postinjection aneurysm versus skeletal muscle contrast ratio by the preinjection contrast ratio. After imaging, the aneurysms were excised and inflammatory infiltrate was characterized by fluorometric detection of myeloperoxidase activity and calprotectin immunostaining, respectively.
RESULTS: In vitro relaxometry showed that oxidation of Fe-PyC3A by hydrogen peroxide resulted in a 15-fold increase of r1 at 3 T. Relaxometry in the presence of blood plasma showed no more than a 10% increase of r1 , indicating the absence of strong interaction of Fe-PyC3A with plasma proteins. Dynamic imaging with Fe-PyC3A generated little signal enhancement within the blood pool or adjacent muscle but did generate a transient increase in aneurysmal ER that was significantly greater 4 weeks versus 12 weeks after aneurysm induction (1.6 ± 0.30 vs 1.2 ± 0.03, P < 0.05). Dynamic imaging with gadobutrol generated strong aneurysmal enhancement, but also strong enhancement of the blood and muscle resulting in smaller relative ER change. In the 12-week group of rabbits, MSDE/TSE imaging showed that ER values measured immediately after dynamic MRI (20 minutes postinjection) were significantly higher ( P < 0.05) in the case of Fe-PyC3A (1.25 ± 0.06) than for gadobutrol injection (1.03 ± 0.03). Immunohistochemical corroboration using anticalprotectin antibody showed that leukocyte infiltration into the vessel walls and luminal thrombi was significantly higher in the 4-week group versus 12-week aneurysms (123 ± 37 vs 18 ± 7 cells/mm 2 , P < 0.05).
CONCLUSIONS: Magnetic resonance imaging using Fe-PyC3A injection in dynamic or delayed acquisition modes was shown to generate a higher magnetic resonance signal enhancement in aneurysms that exhibit higher degree of inflammation. The results of our pilot experiments support further evaluation of MRI using Fe-PyC3A as a noninvasive marker of aneurysmal inflammation.
引用
- King RM, Gounis MJ, Schmidt EJ, et al. Molecular Magnetic Resonance Imaging of Aneurysmal Inflammation Using a Redox Active Iron Complex. Invest Radiol. 2023. PMID: 36822678. doi:10.1097/RLI.0000000000000960
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。